233 Global regulatory landscape for evaluation of products derived from gene editing

Researchers are increasingly excited about the potential of new genetic tools like genome editing to address a wide array of important issues in food and agriculture, including sustainable production, improved nutrition, and animal health and welfare. U.S. regulators and other governments around the world are currently working to develop policies to effectively evaluate the safety of novel products developed with these technologies, but to date, have been sending ambiguous and sometimes conflicting signals about regulatory paths to market. In addition to getting regulatory systems right, successful commercialization of innovative new products may require a broad dialogue about the use of innovation in food and agriculture with a wide array of stakeholders in order to ensure that developers have the social license to bring such products to market. The speaker will review the current global regulatory landscape for evaluation of food and agricultural products derived from gene editing and the potential impact on successful commercialization of such products.